quantify potency of therapeutics targeting the sirpα|cd47 signaling axis
Published 3 years ago • 860 plays • Length 20:34Download video MP4
Download video MP3
Similar videos
-
34:55
advancing therapeutics targeting cytokines with functional cell-based assays
-
23:09
eurofins discoverx custom capabilites
-
38:20
establishing qualified bioassays for checkpoint receptors to implement in qc lot release
-
2:40
trait purity testing at eurofins biodiagnostics
-
0:59
the safety and efficacy of etavopivat in scd
-
28:32
discoverx cytotoxicity cd16 effector cells
-
54:26
let it flow how flow cytometry improves probiotic testing reliability
-
3:51
ipi cell surface receptor research and the opioid crisis
-
37:59
histidine-tagged protein capture using the proteon™ xpr36 system
-
0:30
invitrogen proquantum high-sensitivity immunoassays - minimal sample consumption
-
25:26
discoverx cytotoxicity cell-based assays
-
43:19
building relevant cell based assays for co stimulatory & co inhibitory checkpoint receptors
-
1:42
medical device testing
-
44:09
ready to use potency assays for anti vegf drugs like bevacizumab, ranibizumab & aflibercept
-
7:09
how to run the invitrogen proquantum high sensitivity immunoassay kit
-
1:22
the current and future uses of the immunoscore
-
23:07
eurofins discovery biomarker services
-
0:47
the importance of protein folding in immunoprofiling
-
5:57
ifcc clinical case 29：pretender etp all